Crossmark

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

Crossref DOI link: https://doi.org/10.1186/1471-2407-14-317

Published Online: 2014-05-06

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abubaker, Khalid

Luwor, Rodney B

Zhu, Hongjian

McNally, Orla

Quinn, Michael A

Burns, Christopher J

Thompson, Erik W

Findlay, Jock K

Ahmed, Nuzhat
License Information

License valid from 2014-05-06
More Information

Article History

Received: 8 November 2013

Accepted: 23 April 2014

First Online: 6 May 2014